Pulmonary and Cardiovascular Complications of Obesity: An Autopsy Study of 76 Obese Subjects

Abstract

Context.—Obesity is associated with sleep disordered breathing and cardiovascular morbidity, but the relationship between pulmonary hypertension, heart disease, and obesity is unknown. Objective.—To determine the prevalence of pulmonary and cardiovascular disease in obese subjects undergoing autopsy at a large medical center. Design.—A search through autopsy records from an 11-year period identified 76 subjects with a body mass index greater than 30 kg/m2 and 46 age-matched, nonobese controls. Clinical data were collected from medical charts and autopsy records. Formalin-fixed, paraffin-embedded sections of lungs and heart were reviewed for each subject. The presence of pulmonary edema, hemorrhage, diffuse alveolar damage, thrombi, and pulmonary hypertensive changes, including intimal fibrosis, medial hypertrophy, muscularization of arterioles, alveolar capillary hemangiomatosis, hemosiderosis, and iron encrustation were documented. Hearts were examined for the presence of cardiomegaly, ventricular hypertrophy, coronary artery atherosclerosis, acute infarction, fibrosis, and inflammation. Differences between the obese and control groups were compared using a statistical software program. Results.—The obese group demonstrated a greater occurrence of diabetes mellitus, systemic hypertension, pulmonary edema, hemorrhage, and pulmonary hypertensive changes compared with the control group. Alveolar capillary hemangiomatosis was exclusively observed in the obese subjects. Cardiomegaly and left ventricular hypertrophy were present in all obese subjects; approximately one third of the obese subjects had no coronary atherosclerosis. Conclusions.—Pulmonary hypertensive changes, including venous hypertension and capillary hemangiomatosis, were observed in 72% of obese subjects. Cardiomegaly with biventricular hypertrophy was present in all obese subjects and was suggestive of obesity cardiomyopathy.

Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study

“…7 Interestingly, vascular proliferations in the form of PCH and glomeruloid structures, like those observed in our study, have been described in the lungs of morbid obese patients, a condition that predisposes to severe COVID-19. 8 However, in our series, we did not observe differences in weight between patients with different VS.…”

Obesity‐Related Pulmonary Arterial Hypertension in Rats Correlates with Increased Circulating Inflammatory Cytokines and Lipids and with Oxidant Damage in the Arterial Wall but not with Hypoxia

“…10 Retrospective review of autopsy records also showed that a significant proportion (44%) of obese individuals display medial thickening of the PAs, indicative of subclinical PAH. 10,11 These studies highlight an important link between excess body fat and pathological changes in the pulmonary circulation.…”

Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity‐induced heart failure with preserved ejection fraction with pulmonary hypertension

“…This is, in part, due to a lack of animal models that faithfully recapitulate features of HFpEF, 13 and a lack of understanding of the pathophysiology of RV dysfunction in the context of PH‐HFpEF. Given that obesity and metabolic syndrome are central to the pathogenesis of PH, RV dysfunction, and HFpEF, 8 , 23 , 24 our study validated and extended a relevant, obesity‐induced model of PH and HFpEF to study the pathogenesis of RV dysfunction in HFpEF. Exploiting common genetic variation among available mouse strains to account for effects of diet alone, we identified genes uniquely contributing to the development of RV dysfunction in the context of obesity‐induced PH‐HFpEF.…”